Barbetti Fabrizio, Rapini Novella, Schiaffini Riccardo, Bizzarri Carla, Cianfarani Stefano
Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Diabetology and Growth Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Expert Rev Endocrinol Metab. 2022 Mar;17(2):111-129. doi: 10.1080/17446651.2022.2035216. Epub 2022 Mar 1.
Monogenic diabetes, a form of diabetes mellitus, is caused by a mutation in a single gene and may account for 1-2% of all clinical forms of diabetes. To date, more than 40 loci have been associated with either isolated or syndromic monogenic diabetes.
While the request of a genetic test is mandatory for cases with diabetes onset in the first 6 months of life, a decision may be difficult for childhood or adolescent diabetes. In an effort to assist the clinician in this task, we have grouped monogenic diabetes genes according to the age of onset (or incidental discovery) of hyperglycemia and described the additional clinical features found in syndromic diabetes. The therapeutic options available are reviewed.
Technical improvements in DNA sequencing allow for rapid, simultaneous analysis of all genes involved in monogenic diabetes, progressively shrinking the area of unsolved cases. However, the complexity of the analysis of genetic data requires close cooperation between the geneticist and the diabetologist, who should play a proactive role by providing a detailed clinical phenotype that might match a specific disease gene.
单基因糖尿病是糖尿病的一种形式,由单个基因突变引起,可能占所有临床糖尿病形式的1%至2%。迄今为止,已有40多个基因座与散发性或综合征性单基因糖尿病相关。
虽然对于出生后前6个月内发病的糖尿病患者,基因检测是必需的,但对于儿童或青少年糖尿病患者,做出决策可能会很困难。为了帮助临床医生完成这项任务,我们根据高血糖的发病年龄(或偶然发现)对单基因糖尿病基因进行了分组,并描述了综合征性糖尿病中发现的其他临床特征。同时对可用的治疗选择进行了综述。
DNA测序技术的改进使得能够快速、同时分析所有与单基因糖尿病相关的基因,逐步缩小未解决病例的范围。然而,遗传数据分析的复杂性要求遗传学家和糖尿病专家密切合作,糖尿病专家应通过提供可能与特定疾病基因匹配的详细临床表型发挥积极作用。